Soleno Therapeutics Inc Files Prospectus Relates To Resale By Selling Stockholders Of Up To 3M Shares Of Common Stock
Portfolio Pulse from Benzinga Newsdesk
Soleno Therapeutics Inc has filed a prospectus related to the resale of up to 3 million shares of common stock by selling stockholders, according to an SEC filing.
October 20, 2023 | 8:36 pm
News sentiment analysis
Sort by:
Ascending
NEGATIVE IMPACT
The filing of a prospectus for the resale of up to 3 million shares by selling stockholders could potentially impact the stock price of Soleno Therapeutics Inc.
The resale of a significant number of shares can often lead to a decrease in the stock price due to the increased supply of shares in the market. This could potentially lead to a short-term negative impact on Soleno Therapeutics' stock price.
CONFIDENCE 90
IMPORTANCE 80
RELEVANCE 100